Status:
COMPLETED
Assessing the Accuracy of the RevK Sensor
Lead Sponsor:
University of California, San Francisco
Conditions:
Patients Undergoing Spine Surgery
Eligibility:
All Genders
18-85 years
Brief Summary
Evaluation of a new generation of sensors for monitoring blood hemoglobin. The newest version is RevK.
Detailed Description
Evaluation of a new generation of sensors for monitoring blood hemoglobin with the Masimo non-invasive hemoglobin monitor. The newest sensor version is RevK.
Eligibility Criteria
Inclusion
- Male or non-pregnant female
- American Society of Anesthesiology Classification 1, 2 or 3
- Scheduled to undergo spine or hip surgery
Exclusion
- Pregnant or nursing
- Patients who in the study investigators clinical judgement would not be suitable for research
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT01877876
Start Date
June 1 2013
End Date
June 1 2015
Last Update
June 10 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143